New antiglaucoma drug to go on sale

Allergan Korea said it will launch via its local agent Samil Pharm Lumigan (bimatoprost ophthalmic solution) 0.03%, which is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are intolerant of other IOP-lowering medications or insufficiently responsive to another IOP-lowering medication.

The U.S. Food and Drug A...